Morphine Extended-Release Capsules and Relafen DS
Determining the interaction of Morphine Extended-Release Capsules and Relafen DS and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: nabumetone
Brand name: Relafen DS, Relafen
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Relagesic
- Morphine Extended-Release Capsules-Relamine
- Morphine Extended-Release Capsules-Relasin-HC
- Morphine Extended-Release Capsules-Relcof C
- Morphine Extended-Release Capsules-Relcof DM
- Morphine Extended-Release Capsules-Releevia
- Relafen DS-Morphine Immediate-Release Tablets and Capsules
- Relafen DS-Morphine injection
- Relafen DS-Morphine Injection PF
- Relafen DS-Morphine Long-Acting Tablets
- Relafen DS-Morphine Oral Concentrate (20 mg/mL)
- Relafen DS-Morphine Oral Solution